American Association for Cancer Research
21598290cd150921-sup-153389_3_supp_0_j6m8y2.pdf (90.8 kB)

Supplementary Tables 8 - 9 from LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern

Download (90.8 kB)
journal contribution
posted on 2023-04-03, 21:06 authored by Tian-Tian Sun, Jie He, Qian Liang, Lin-Lin Ren, Ting-Ting Yan, Ta-Chung Yu, Jia-Yin Tang, Yu-Jie Bao, Ye Hu, Yanwei Lin, Danfeng Sun, Ying-Xuan Chen, Jie Hong, Haoyan Chen, Weiping Zou, Jing-Yuan Fang

Supplementary Table 8. Sequence of primers for real-time PCR. Supplementary Table 9. Sequence of primers for CHIP real-time PCR.


National Natural Science Foundation of China

Shanghai Natural Science Foundation

Shanghai Jiao Tong University



Long noncoding RNAs (lncRNA) play a role in carcinogenesis. However, the function of lncRNAs in human gastric cancer remains largely unknown. In this study, we identified a novel lncRNA, GClnc1, which was upregulated and associated with tumorigenesis, tumor size, metastasis, and poor prognosis in gastric cancer. GClnc1 affected gastric cancer cell proliferation, invasiveness, and metastasis in multiple gastric cancer models. Mechanistically, GClnc1 bound WDR5 (a key component of histone methyltransferase complex) and KAT2A histone acetyltransferase, acted as a modular scaffold of WDR5 and KAT2A complexes, coordinated their localization, specified the histone modification pattern on the target genes, including SOD2, and consequently altered gastric cancer cell biology. Thus, GClnc1 is mechanistically, functionally, and clinically oncogenic in gastric cancer. Targeting GClnc1 and its pathway may be meaningful for treating patients with gastric cancer.Significance: This report documents a novel lncRNA, GClnc1, which may act as a scaffold to recruit the WDR5 and KAT2A complex and modify the transcription of target genes. This study reveals that GClnc1 is an oncogenic lncRNA in human gastric cancer. Cancer Discov; 6(7); 784–801. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 681

Usage metrics

    Cancer Discovery